phloretin has been researched along with Lung Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunimasa, K | 1 |
| Nagano, T | 1 |
| Shimono, Y | 1 |
| Dokuni, R | 1 |
| Kiriu, T | 1 |
| Tokunaga, S | 1 |
| Tamura, D | 1 |
| Yamamoto, M | 1 |
| Tachihara, M | 1 |
| Kobayashi, K | 1 |
| Satouchi, M | 1 |
| Nishimura, Y | 1 |
1 other study available for phloretin and Lung Adenocarcinoma
| Article | Year |
|---|---|
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; | 2017 |